Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000386214

Medchemexpress LLC Pantoprazole | 102625-70-7 | 99.95% | 383.37 | 1 ML
SDP

Catalog No. 5000386214
Encompass_Preferred

Pantoprazole (BY10232) is an orally active and potent proton pump inhibitor (PPI). It is a substituted benzimidazole and a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. Pantoprazole improves pH stability and possesses anti-secretory and anti-ulcer activities. It also significantly increased tumor growth delay when combined with Doxorubicin.

  • Orally active and potent proton pump inhibitor (PPI)
  • Substituted benzimidazole
  • Potent H+/K+-ATPase inhibitor with an an IC50 of 6.8 μM
  • Improves pH stability
  • Anti-secretory and anti-ulcer activities
  • Increased tumor growth delay in combination with Doxorubicin

Catalog No. 50-003-86214 Supplier Medchemexpress LLC Supplier No. HY1750710MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Pantoprazole (BY10232) is an orally active and potent proton pump inhibitor (PPI). It is a substituted benzimidazole and a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. Pantoprazole improves pH stability and possesses anti-secretory and anti-ulcer activities. It also significantly increased tumor growth delay when combined with Doxorubicin.

  • Orally active and potent proton pump inhibitor (PPI)
  • Substituted benzimidazole
  • Potent H+/K+-ATPase inhibitor with an an IC50 of 6.8 μM
  • Improves pH stability
  • Anti-secretory and anti-ulcer activities
  • Increased tumor growth delay in combination with Doxorubicin

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.